MHP
CLPT icon

Manatuck Hill Partners’s ClearPoint Neuro CLPT Stock Holding History

Manatuck Hill Partners’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-75,000
Closed -$841K – 114
2024
Q3 		$841K Hold
75,000
– – 0.31% 76
2024
Q2 		$404K Hold
75,000
– – 0.17% 94
2024
Q1 		$510K Buy
+75,000
New +$524K 0.22% 89

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Manatuck Hill Partners's CLPT Position: Q4 2024 in Review

Manatuck Hill Partners sold out of ClearPoint Neuro (CLPT) in Q4 2024, closing a stake of 75,000 shares — an estimated $841K sold.

Manatuck Hill Partners first reported a position in CLPT in Q1 2024 and held it in 3 quarters. The position peaked at $841K in Q3 2024. 89 funds tracked by Wall St. Rank hold CLPT as of Q4 2024.

  • Manatuck Hill Partners reported no remaining ClearPoint Neuro position as of Q4 2024 after selling out during the quarter.
  • Manatuck Hill Partners sold 75,000 ClearPoint Neuro shares in Q4 2024, an estimated $841K.
  • Manatuck Hill Partners first reported a position in ClearPoint Neuro in Q1 2024 and held it in 3 quarters.
  • Manatuck Hill Partners's ClearPoint Neuro position peaked at $841K in Q3 2024.
  • 89 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2024.

Based on Manatuck Hill Partners's 13F filing for Q4 2024, filed 14 Feb 2025.